High co‐expression of <scp>SLC7A11</scp> and <scp>GPX4</scp> as a predictor of platinum resistance and poor prognosis in patients with epithelial ovarian cancer
Xiaodong Wu(Women's Hospital, School of Medicine, Zhejiang University), Xiaodong Cheng(Women's Hospital, School of Medicine, Zhejiang University), Jiale Qin(Women's Hospital, School of Medicine, Zhejiang University), Weidong Fei(Women's Hospital, School of Medicine, Zhejiang University), Shizhen Shen(Women's Hospital, School of Medicine, Zhejiang University), Jiaxin Gu(Women's Hospital, School of Medicine, Zhejiang University), Tao Shen(Jinan University), Fengyun Fan(Women's Hospital, School of Medicine, Zhejiang University), Tao Zhang(Sichuan University)
Cited by 69
Related Papers
LncRNA CRNDE acts as an oncogene in cervical cancer through sponging miR-183 to regulate CCNB1 expression
|Carcinogenesis|2019|82
Comprehensive pan-cancer analysis reveals EPHB2 is a novel predictive biomarker for prognosis and immunotherapy response
|BMC Cancer|2024|52
The anti-tumor effect of aspirin: What we know and what we expect
|Biomedicine & Pharmacotherapy|2017|50